"Imbalanced host response to #SARSCoV2 drives development of #COVID19"
Highlighting
"We propose that reduced innate #antiviral defenses coupled with exuberant inflammatory #cytokine production are the defining and driving feature of COVID-19"
https://www.cell.com/pb-assets/products/coronavirus/CELL_CELL-D-20-00985.pdf




https://www.cell.com/pb-assets/products/coronavirus/CELL_CELL-D-20-00985.pdf



#SARSCoV2

culminates in the oligomerization of these receptors and the activation of downstream transcription factors, most notably the interferon regulator factors (IRFs) and Nuclear Factor (NF)."

#SARSCoV2


#SARSCoV2


#SARSCoV2






#Ferrets #SARSCoV2 #infection


(IAV) = influenza A virus /vs/ #SARS_COV_2







which recruit monocytes/macrophages, and CXCL8, a classic neutrophil chemoattractant, suggest that the presence of these cells may be a primary driver of the
signature #pathology...
...observed in #COVID19 patients."
"This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020; Qin et al., 2020), which may have prognostic value in identifying individuals at risk for developing severe disease."




...producing sufficient amounts of IFN-I and/or IFN-III to
guide immune cell activation and ISG induction."
https://www.cell.com/pb-assets/products/coronavirus/CELL_CELL-D-20-00985.pdf
#SARSCoV2 #biochemistry #immune #response #COVID19
guide immune cell activation and ISG induction."

https://www.cell.com/pb-assets/products/coronavirus/CELL_CELL-D-20-00985.pdf
#SARSCoV2 #biochemistry #immune #response #COVID19